1. Home
  2. Product
  3. Inhibitors
  4. Bisindolylmaleimide II
Bisindolylmaleimide II Assay:≥97% (isomer mixture)A crystalline solid Inhibitors Potent, ATP-competitive protein kinase C (PKC) inhibitor (IC50 = 0.01 μM). Displays selectivity for PKC over protein kinase A (PKA) and phosphorylase kinase (PK) (IC50 values are 0.75 and 2μM for PK and PKA respectively). Also displays potent, noncompetitive antagonism at nicotinic cholinergic receptors (IC50 ~ 0.03 μM for inhibition of catecholamine secretion in nicotine-stimulated PC-12 cells). 438.5 g/mol
$ $99 In stock
Formulation: 438.5 g/mol
Source:
Usage:
Bisindolylmaleimide II - 137592-45-1

Bisindolylmaleimide II

The product is for non-human research only. Not for therapeutic or veterinary use.

Catalog Number: BT-254475

CAS Number: 137592-45-1

Molecular Formula: C27H26N4O2

Molecular Weight: 438.5 g/mol

CAS Number 137592-45-1
Product Name Bisindolylmaleimide II
Molecular Formula C27H26N4O2
Molecular Weight 438.5 g/mol
Appearance Assay:≥97% (isomer mixture)A crystalline solid
InChI InChI=1S/C27H26N4O2/c1-30-13-6-7-17(30)12-14-31-16-21(19-9-3-5-11-23(19)31)25-24(26(32)29-27(25)33)20-15-28-22-10-4-2-8-18(20)22/h2-5,8-11,15-17,28H,6-7,12-14H2,1H3,(H,29,32,33)
InChI Key LBFDERUQORUFIN-UHFFFAOYSA-N
IUPAC Name 3-(1H-indol-3-yl)-4-[1-[2-(1-methylpyrrolidin-2-yl)ethyl]indol-3-yl]pyrrole-2,5-dione
Canonical SMILES CN1CCCC1CCN2C=C(C3=CC=CC=C32)C4=C(C(=O)NC4=O)C5=CNC6=CC=CC=C65
Description Potent, ATP-competitive protein kinase C (PKC) inhibitor (IC50 = 0.01 μM). Displays selectivity for PKC over protein kinase A (PKA) and phosphorylase kinase (PK) (IC50 values are 0.75 and 2μM for PK and PKA respectively). Also displays potent, noncompetitive antagonism at nicotinic cholinergic receptors (IC50 ~ 0.03 μM for inhibition of catecholamine secretion in nicotine-stimulated PC-12 cells).
SMILES CN1CCCC1CCN2C=C(C3=CC=CC=C32)C4=C(C(=O)NC4=O)C5=CNC6=CC=CC=C65
Synonyms 3-(1H-Indol-3-yl)-4-[1-[2-(1-methyl-2-pyrrolidinyl)ethyl]-1H-indol-3-yl]-1H-pyrrole-2,5-dione
PubChem Compound Bisindolylmaleimide II
Last Modified Apr 08 2022